Towards a human Lassa fever vaccine

Reviews in Medical Virology

Volumn 11, Issue 5, 2001, Pages 331-341

  Fisher Hoch, S P ^a   McCormick, J B ^a  

^a UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ARENAVIRUS; CELLULAR IMMUNITY; CLINICAL TRIAL; GENE CONSTRUCT; GUINEA PIG; HEMORRHAGIC FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; LASSA VIRUS; NONHUMAN; PRIMATE; PROTEIN EXPRESSION; REVIEW; RNA VIRUS INFECTION; RODENT DISEASE; SEROPREVALENCE; T LYMPHOCYTE ACTIVATION; VACCINATION; VACCINIA VIRUS; VIRUS EXPRESSION; VIRUS TRANSMISSION;

AFRICA, WESTERN; ANIMALS; ANTIBODIES, VIRAL; GUINEA PIGS; HAPLORHINI; HUMANS; LASSA FEVER; LASSA VIRUS; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0034774693     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.329     Document Type: Review

References (47)

1. Isolation and antigenic characterization of Lassa virus
2. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus
3. Arenaviridae and their replication
4. A prospective study of the epidemiology and ecology of Lassa fever
5. Phylogenetic analysis of the Arenaviridae: Patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts
6. Genetic diversity among Lassa virus strains
7. Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa
8. Mapping arenavirus genes causing virulence
9. Sequence comparison of the large genomic RNA segments of two strains of lymphocytic choriomeningitis virus differing in pathogenic potential for guinea pigs
10. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies
11. Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia
12. Viral hemorrhagic fever antibodies in Nigerian populations
13. Lassa fever in children in Sierra Leone, West Africa
14. Pediatric Lassa fever: A review of 33 Liberian cases
15. Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice
16. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972
17. Emergence of epidemic Lassa fever during civil conflict in Sierra Leone
18. Lassa fever, imported case, Netherlands [news]
19. Lassa fever imported to England
20. A case-control study of the clinical diagnosis and course of Lassa fever
21. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy
22. Acute sensorineural deafness in Lassa fever
23. Arenavirus gene structure and organization
24. Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus
25. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies
26. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome
27. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin
28. Clinical virology of Lassa fever in hospitalized patients
29. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein
30. Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques
31. Stringent precautions are not advisable when caring for patients with viral haemorrhagic fevers
32. No evidence for increased risk of Lassa fever infection in hospital staff
33. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever
34. Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus
35. Effective vaccine for Lassa fever
36. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene
37. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses
38. Molecular cloning of Lassa virus RNA: Nucleotide sequence and expression of the nucleocapsid protein gene
39. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guinea pigs against Lassa fever
40. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection
41. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus
42. Construction and evaluation of recombinant virus vaccines for Lassa fever
43. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus
44. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses
45. Canarypox virus-based vaccines: Prime-boost strategies to induce cell-mediated and humoral immunity against HIV
46. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution
47. Immunisation strategies for viral diseases in developing countries